TCIRG1 and cholangiocarcinoma: This study was built on these breakthrough advancements in the field of oncology and aimed to examine the presence of a distinct subset of immune cells expressing the transmembrane protein TIRC7 in CCA and to analyze its correlation with clinicopathological parameters.